Oncostatin M promotes chronic pain through direct regulation on nociceptors in rats
- 30 January 2026
- journal article
- Published by Wolters Kluwer Health in Pain
- Vol. 167 (6) , 1370-1380
Abstract
Oncostatin M (OSM), a member of the interleukin 6 (IL-6) pro-inflammatory cytokine family, is upregulated in the dorsal root ganglia of patients with neuropathic pain and thus may be an important contributor to this condition. Although suggested to contribute to itch in mice, the effects of OSM on nociceptive behavior and nociceptors in rats remain undefined. Here we show that a singular intrathecal dose of OSM (10 ng) induces significant mechanical hypersensitivity in both sexes of rats, yet does not alter thermal withdrawal latencies. When applied to cultured rat dorsal root ganglion (DRG) neurons, OSM (10 ng/mL) elicited robust action potential discharges and exaggerated fluctuations in membrane potential that was not mitigated by an IL-6 receptor antagonist. Neurons reactive to OSM typically did not respond to capsaicin, aligning with the behavioral observations. Immunohistochemical analysis revealed frequent co-localization of OSM and its receptor (OSMR) with isolectin B4–positive and calcitonin gene–related peptide–positive DRG neurons, but only scarce co-localization in transient receptor potential vanilloid 1–positive DRG neurons. In a model of paclitaxel chemotherapy–induced peripheral neuropathy, there is a notable increase in DRG neurons expressing OSM or its receptor (OSMR), alongside an upsurge in several OSM/OSMR downstream signaling molecules. These findings suggest that OSM acts as a signal for mechanical nociception and that heightened OSM expression and OSMR signaling in the DRG may be a key factor in the sensitization of specific nociceptor subsets. Consequently, targeting the OSM/OSMR pathway may offer a promising avenue for treatment in particular neuropathic pain phenotypes.Keywords
Funding Information
- National Institute of Neurological Disorders and Stroke (NS111929)
- National Institute of Neurological Disorders and Stroke (NS130608)
- National Institute of Neurological Disorders and Stroke (NS132483)
- National Institute of Neurological Disorders and Stroke (NS065926)
- National Institute of Neurological Disorders and Stroke (NS111929)
- National Institute of Neurological Disorders and Stroke (NS130608)
- National Institute of Neurological Disorders and Stroke (NS065926)
This publication has 72 references indexed in Scilit:
- Differential Binding of Sarilumab and Tocilizumab to IL‐6Rα and Effects of Receptor Occupancy on Clinical ParametersThe Journal of Clinical Pharmacology, 2020
- Upregulation of CCL2 via ATF3/c-Jun interaction mediated the Bortezomib-induced peripheral neuropathyBrain, Behavior, and Immunity, 2016
- The immune aspect in neuropathic pain: Role of chemokinesActa Anaesthesiologica Taiwanica, 2013
- Signaling network of Oncostatin M pathwayJournal of Cell Communication and Signaling, 2012
- Persistent chemoneuropathy in patients receiving the plant alkaloids paclitaxel and vincristineCancer Chemotherapy and Pharmacology, 2012
- Amelioration of arthritis in two murine models using antibodies to Oncostatin MArthritis & Rheumatism, 2001
- Multiple capsaicin-induced currents in isolated rat sensory neuronsNeuroscience, 1996
- Quantitative assessment of tactile allodynia in the rat pawJournal of Neuroscience Methods, 1994
- Interactions between oncostatin M and the IL-6 signal transducer, gp130Cytokine, 1994
- Peripheral neuropathy from taxol and cisplatin combination chemotherapy: Clinical and electrophysiological studiesAnnals of Neurology, 1994